On the other hand, there is also evidence that activated AR can inhibit HCC metastasis by inducing cellular apoptosis by modulation of p38 kinase phosphorylation [104], shown to be mitogenic-dependent and playing a significant role in HCC [105,106,107]. This evidence concerns the gene AR and hepatocellular carcinoma.